Similar articles for PMID: 22611059

Year	Number of Results
1989	1
1994	1
1997	2
1999	2
2002	2
2003	2
2004	5
2005	5
2006	6
2007	14
2008	6
2009	14
2010	9
2011	14
2012	26
2013	11
2014	12
2015	6
2016	4
2017	6
2018	4
2019	4
2020	2
2021	2
2024	0

1

The promise of immunisation against rotavirus.

Marlow RD, Finn A. Marlow RD, et al. Arch Dis Child. 2012 Aug;97(8):736-40. doi: 10.1136/archdischild-2011-301472. Epub 2012 May 18. Arch Dis Child. 2012. PMID: 22611059 Review.

2

Rotavirus vaccines: targeting the developing world.

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD. Glass RI, et al. J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6. doi: 10.1086/431504. J Infect Dis. 2005. PMID: 16088799

3

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD. Atherly DE, et al. Vaccine. 2012 Apr 27;30 Suppl 1:A7-14. doi: 10.1016/j.vaccine.2011.12.096. Vaccine. 2012. PMID: 22520139

4

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.

Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ. Tu HA, et al. Vaccine. 2012 Feb 14;30(8):1521-8. doi: 10.1016/j.vaccine.2011.11.052. Epub 2011 Nov 23. Vaccine. 2012. PMID: 22119590

5

Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.

Madsen LB, Ustrup M, Hansen KS, Nyasulu PS, Bygbjerg IC, Konradsen F. Madsen LB, et al. Trop Med Int Health. 2014 Feb;19(2):177-85. doi: 10.1111/tmi.12233. Epub 2013 Dec 9. Trop Med Int Health. 2014. PMID: 24314006 Free article.

6

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.

Tate JE, Patel MM, Cortese MM, Lopman BA, Gentsch JR, Fleming J, Steele AD, Parashar UD. Tate JE, et al. Expert Rev Vaccines. 2012 Feb;11(2):211-20. doi: 10.1586/erv.11.184. Expert Rev Vaccines. 2012. PMID: 22309669 Review.

7

Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.

Muangchana C, Riewpaiboon A, Jiamsiri S, Thamapornpilas P, Warinsatian P. Muangchana C, et al. Vaccine. 2012 Apr 16;30(18):2839-47. doi: 10.1016/j.vaccine.2012.02.047. Epub 2012 Mar 2. Vaccine. 2012. PMID: 22387220

8

Rotavirus vaccines: entering a new stage of deployment.

Nakagomi O, Cunliffe NA. Nakagomi O, et al. Curr Opin Infect Dis. 2007 Oct;20(5):501-7. doi: 10.1097/QCO.0b013e3282a56ba0. Curr Opin Infect Dis. 2007. PMID: 17762784 Review.

9

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC. O'Ryan M, et al. Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Expert Rev Vaccines. 2009. PMID: 19943758 Review.

10

Rotavirus vaccines in developed countries.

Buttery JP, Kirkwood C. Buttery JP, et al. Curr Opin Infect Dis. 2007 Jun;20(3):253-8. doi: 10.1097/QCO.0b013e32813aeaac. Curr Opin Infect Dis. 2007. PMID: 17471034 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

147 results

Results by year